Therapy for dyskinesias in Parkinson’s disease patients
✍ Scribed by Stefani, Alessandro; Pierantozzi, Mariangela; Koch, Giacomo; Galati, Salvatore; Stanzione, Paolo
- Book ID
- 120442117
- Publisher
- Future Medicine
- Year
- 2010
- Tongue
- English
- Weight
- 877 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1479-6708
- DOI
- 10.2217/fnl.10.9
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Existing and emerging strategies for managing L‐dopa–induced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of L‐dopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop
## Abstract Dyskinesia is a common adverse effect complicating chronic dopaminergic therapy for Parkinson's disease. Movements are frequently choreic in nature and have been ascribed to overstimulation of “supersensitive” striatal postsynaptic dopamine receptors. Anticholinergic medications, despit